Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors ; volume:7 ; number:1 ; day:20 ; month:2 ; year:2024 ; pages:1-14 ; date:12.2024
Communications chemistry ; 7, Heft 1 (20.2.2024), 1-14, 12.2024
- Klassifikation
-
Chemie
- Urheber
-
Wittlinger, Florian
Ogboo, Blessing C.
Shevchenko, Ekaterina
Damghani, Tahereh
Pham, Calvin D.
Schaeffner, Ilse K.
Oligny, Brandon T.
Chitnis, Surbhi P.
Beyett, Tyler S.
Rasch, Alexander
Buckley, Brian
Urul, Daniel A.
Shaurova, Tatiana
May, Earl W.
Schaefer, Erik M.
Eck, Michael J.
Hershberger, Pamela A.
Poso, Antti
Laufer, Stefan
Heppner, David E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s42004-024-01108-3
- URN
-
urn:nbn:de:101:1-2404291021408.177162397212
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wittlinger, Florian
- Ogboo, Blessing C.
- Shevchenko, Ekaterina
- Damghani, Tahereh
- Pham, Calvin D.
- Schaeffner, Ilse K.
- Oligny, Brandon T.
- Chitnis, Surbhi P.
- Beyett, Tyler S.
- Rasch, Alexander
- Buckley, Brian
- Urul, Daniel A.
- Shaurova, Tatiana
- May, Earl W.
- Schaefer, Erik M.
- Eck, Michael J.
- Hershberger, Pamela A.
- Poso, Antti
- Laufer, Stefan
- Heppner, David E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of imidazole-based ATP-allosteric bivalent epidermal growth factor receptor inhibitors with mutant-selectivity
Covalent-allosteric inhibitors to achieve akt isoform-selectivity
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
Allosteric effect of ATP on Na+,K+-ATPase conformational kinetics
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
Allosteric activation unveils protein-mass modulation of ATP phosphoribosyltransferase product release
Allosteric probe initiated triple signal recycles for sensitive analysis of adenosine triphosphate (ATP)
Dinucleosome specificity and allosteric switch of the ISW1a ATP-dependent chromatin remodeler in transcription regulation
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors
Allosteric rescue of catalytically impaired ATP phosphoribosyltransferase variants links protein dynamics to active-site electrostatic preorganisation
Nonclassical crystallization of bivalent metal carbonates
Development of imidazole-based ATP-allosteric bivalent epidermal growth factor receptor inhibitors with mutant-selectivity
Covalent-allosteric inhibitors to achieve akt isoform-selectivity
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
Allosteric effect of ATP on Na+,K+-ATPase conformational kinetics
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
Allosteric activation unveils protein-mass modulation of ATP phosphoribosyltransferase product release
Allosteric probe initiated triple signal recycles for sensitive analysis of adenosine triphosphate (ATP)
Dinucleosome specificity and allosteric switch of the ISW1a ATP-dependent chromatin remodeler in transcription regulation
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors
Allosteric rescue of catalytically impaired ATP phosphoribosyltransferase variants links protein dynamics to active-site electrostatic preorganisation
Nonclassical crystallization of bivalent metal carbonates
Development of imidazole-based ATP-allosteric bivalent epidermal growth factor receptor inhibitors with mutant-selectivity
Covalent-allosteric inhibitors to achieve akt isoform-selectivity
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
Allosteric effect of ATP on Na+,K+-ATPase conformational kinetics
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
Allosteric activation unveils protein-mass modulation of ATP phosphoribosyltransferase product release
Allosteric probe initiated triple signal recycles for sensitive analysis of adenosine triphosphate (ATP)
Dinucleosome specificity and allosteric switch of the ISW1a ATP-dependent chromatin remodeler in transcription regulation
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors
Allosteric rescue of catalytically impaired ATP phosphoribosyltransferase variants links protein dynamics to active-site electrostatic preorganisation